Clinical trial
Mirai-MRI: Multi-site Prospective Validation of AI Models for Breast Cancer Risk
NCT07121972 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mirai-MRI: Multi-site Prospective Validation of AI Models for Breast Cancer Risk
- Lead sponsor
- University of California, San Francisco
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 3, 2025
- Completion date
- January 31, 2027
- Enrollment
- 400 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer risk, cancer risk